Work Here?
Industries
Venture Capital
Fintech
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
$15.4B
Headquarters
New York City, New York
Founded
2015
B Capital Group is a global investment firm that focuses on providing capital and support to entrepreneurs in the Technology, Healthcare, and Climate sectors. The firm manages over $6 billion in assets and invests in companies at various stages, from seed to late-stage growth. B Capital's approach includes not only financial investment but also strategic assistance, helping companies to scale efficiently and enter new markets. A key aspect that sets B Capital apart from its competitors is its partnership with the Boston Consulting Group (BCG), which enhances the support they offer to entrepreneurs. The goal of B Capital is to shape the future through technology by empowering exceptional entrepreneurs to build successful businesses.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$15389.8M
Above
Industry Average
Funded Over
0 Rounds
Hybrid Work Options
NEW YORK--(BUSINESS WIRE)--Odeko, the all-in-one operation and technology partner for thousands of local coffee shops, cafes, and other food and beverage businesses, today announced it has raised $126 million in Series E funding, comprised of $96 million in equity led by B Capital and a $30 million credit facility from
B Capital, Capital Factory and Google back Apptronik in the race to develop and deploy humanoid robots at scale
Mistral AI, France’s open-source answer to OpenAI, plans to go public instead of being acquired. “We are not for sale,” CEO and co-founder Arthur Mensch told Bloomberg TV Tuesday (Jan. 21). There had been speculation that the startup would be acquired by Microsoft, in part due to a partnership and the tech giant’s investment of 15 million euros ($15.6 million) in Mistral. (Microsoft has invested nearly $14 billion in OpenAI.)
Labviva, an AI procurement platform for life sciences, secured $25 million in Series B funding, totaling $55 million. Led by 53 Stations, with participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the funds will accelerate product development, marketing, and global expansion. Jason Pritzker from 53 Stations joins Labviva's Board. Labviva aims to enhance supply chain transparency and efficiency in life sciences, supporting major pharmaceutical companies and research institutions.
Innovaccer has raised a $275M Series F from investors including B Capital Group, Banner Health, Danaher Ventures, Generation IM, Kaiser Permanente, and M12.
Find jobs on Simplify and start your career today
Industries
Venture Capital
Fintech
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
$15.4B
Headquarters
New York City, New York
Founded
2015
Find jobs on Simplify and start your career today